Drug-eluting beads loaded with irinotecan to treat synchronous liver-only metastases of colorectal cancer non-responsive to bevacizumab-based chemotherapy.

Ting-Fu HsuWei-Chou ChangPing-Ying ChangHsuan-Hwai LinPin-Ko ChenKai-Hsiang KoSung-Hua Chiu

Published in: The British journal of radiology (2023)

DEBIRI can act as an acceptable locoregional management in CRC patients with liver metastases non-responsive to BBC, and the pre-DEBIRI CER is a potential indicator of locoregional control.

Keyphrases

liver metastases
cancer therapy
drug delivery
squamous cell carcinoma
human health
metastatic colorectal cancer
risk assessment
radiation therapy
rectal cancer